| Not Yet Recruiting | A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations Parkinson's Disease | Phase 2 | 2026-06-30 |
| Not Yet Recruiting | A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD) Parkinson Disease | Phase 1 | 2026-03-31 |
| Active Not Recruiting | A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications Migraine | Phase 4 | 2024-12-18 |
| Active Not Recruiting | A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA) Multiple System Atrophy | Phase 3 | 2024-12-03 |
| Active Not Recruiting | A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease Thyroid Eye Disease | Phase 1 | 2024-09-19 |
| Completed | A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine Migraine | Phase 1 | 2024-09-13 |
| Recruiting | A Trial of Lu AG13909 in Adult Participants With Cushing's Disease Cushing's Disease | Phase 2 | 2024-06-19 |
| Completed | A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men Healthy Participants | Phase 1 | 2024-04-10 |
| Active Not Recruiting | A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Trea Migraine | Phase 2 | 2024-04-01 |
| Completed | A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults Healthy Participants | Phase 1 | 2024-03-18 |
| Completed | A Trial Investigating Lu AF28996 in Healthy Adult Participants Healthy Participants | Phase 1 | 2024-02-27 |
| Completed | A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants Healthy Participants | Phase 1 | 2023-10-13 |
| Completed | A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD) Parkinson Disease | Phase 1 | 2023-09-12 |
| Terminated | A Study Investigating Lu AG06474 in Healthy Young Participants Healthy Participants | Phase 1 | 2023-06-28 |
| Recruiting | A Study of Eptinezumab in Pediatric Participants With Episodic Migraine Episodic Migraine | Phase 3 | 2023-06-08 |
| Recruiting | A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia Congenital Adrenal Hyperplasia | Phase 1 / Phase 2 | 2022-12-19 |
| Completed | A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache Migraine, Medication Overuse Headache | Phase 4 | 2022-07-01 |
| Active Not Recruiting | Observational Study in Multiple System Atrophy Multiple System Atrophy | — | 2022-06-25 |
| Completed | A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants Healthy Participants | Phase 1 | 2022-03-31 |
| Completed | A Brain Imaging PET Study of [11C]-Lu AF90103 in Healthy Adult Male Participants Healthy Young Men | Phase 1 | 2022-03-23 |
| Completed | A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chin Migraine | Phase 1 | 2022-03-18 |
| Completed | A Study Investigating Lu AG22515 in Healthy Adults Healthy Participants | Phase 1 | 2022-03-18 |
| Terminated | Real World Effectiveness of Eptinezumab in Participants With Migraine Migraine | Phase 4 | 2022-03-04 |
| Completed | Binding and Effects of Lu AG06466 in the Brain of Healthy Men Healthy Participants | Phase 1 | 2022-01-18 |
| Completed | A Study Investigating Lu AG06466 in Healthy Men Healthy Volunteers | Phase 1 | 2022-01-05 |
| Recruiting | A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine Migraine | Phase 3 | 2021-12-01 |
| Terminated | Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian Participants Healthy Volunteers | Phase 1 | 2021-11-26 |
| Active Not Recruiting | A Study of Lu AF82422 in Participants With Multiple System Atrophy Multiple System Atrophy | Phase 2 | 2021-11-16 |
| Completed | A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments Migraine | Phase 2 | 2021-11-11 |
| Completed | A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Allergic Rhinitis | Phase 1 | 2021-11-01 |
| Terminated | A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy Focal Epilepsy | Phase 1 | 2021-09-29 |
| Completed | A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines Healthy Participants | Phase 1 | 2021-09-27 |
| Terminated | A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis Multiple Sclerosis | Phase 1 | 2021-09-27 |
| Completed | Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan Migraine | Phase 3 | 2021-09-21 |
| Completed | A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache Chronic Cluster Headache | Phase 3 | 2021-09-17 |
| Completed | A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants Healthy | Phase 1 | 2021-08-23 |
| Terminated | Vortioxetine to Prevent Return of Symptoms in Children With Depression Depression | Phase 3 | 2021-08-10 |
| Completed | Safety and Tolerability of Lu AG06474 in Healthy Young Men Healthy | Phase 1 | 2021-08-04 |
| Completed | A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects Healthy | Phase 1 | 2021-07-15 |
| Recruiting | A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine Chronic Migraine in Children | Phase 3 | 2021-06-30 |
| Terminated | A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia Fibromyalgia | Phase 1 | 2021-06-24 |
| Completed | Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine Migraine | Phase 3 | 2021-05-29 |
| Terminated | A Study to Evaluate Lu AF90103 in Healthy Men Healthy | Phase 1 | 2021-05-26 |
| Completed | Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese Subjects Healthy | Phase 1 | 2021-04-20 |
| Completed | Eptinezumab in Adults With Migraine and Medication Overuse Headache Migraine, Medication Overuse Headache | Phase 3 | 2021-02-17 |
| Completed | Eptinezumab in Participants With Episodic Cluster Headache Cluster Headache, Episodic | Phase 3 | 2020-12-23 |
| Completed | Drug Drug Interaction Study With Lu AG06466 in Young Healthy Men Healthy | Phase 1 | 2020-12-08 |
| Completed | Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD) PTSD | Phase 1 | 2020-09-30 |
| Completed | A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the Brain Healthy | Phase 1 | 2020-08-24 |
| Completed | A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab Migraine in Children, Migraine | Phase 1 | 2020-08-04 |
| Terminated | Safety and Tolerability of Lu AG06479 in Healthy Young Men Healthy | Phase 1 | 2020-07-09 |
| Completed | Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression Major Depressive Disorder | Phase 4 | 2020-06-18 |
| Completed | A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Migraine | Phase 3 | 2020-06-01 |
| Completed | Binding of Lu AG06466 in the Brain in Healthy Men Healthy | Phase 1 | 2020-05-29 |
| Completed | Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women Healthy | Phase 1 | 2020-05-20 |
| Completed | Eptinezumab in Healthy Japanese Subjects Healthy | Phase 1 | 2020-04-01 |
| Completed | Vortioxetine in Patients With Depression and Early Dementia Major Depressive Disorder, Dementia | Phase 4 | 2020-02-28 |
| Completed | Lu AF28996 in Participants With Parkinson's Disease (PD) Parkinson Disease | Phase 1 | 2020-02-26 |
| Completed | Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India Major Depressive Disorder | Phase 4 | 2020-02-20 |
| Completed | Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects Healthy | Phase 1 | 2020-02-10 |
| Terminated | Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects Parkinson Disease, Healthy | Phase 1 | 2020-01-23 |
| Completed | Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD) MDD, Anxiety Disorders | Phase 4 | 2019-12-27 |
| Terminated | Safety and Tolerability of Lu AF95245 in Healthy Young Men Healthy | Phase 1 | 2019-12-10 |
| Terminated | Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease Healthy, Parkinson Disease | Phase 1 | 2019-11-12 |
| Completed | A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experien Migraine | Phase 3 | 2019-11-07 |
| Completed | Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease Healthy, Alzheimer Disease | Phase 1 | 2019-09-27 |
| Completed | Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman Migraine | Phase 1 | 2019-09-24 |
| Completed | A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects Healthy | Phase 1 | 2019-09-17 |
| Completed | Study Investigating the Safety and Tolerability of Lu AF88434 in Healthy Young Men Healthy | Phase 1 | 2019-07-23 |
| Completed | What the Body Does to Foliglurax in Healthy Volunteers Healthy | Phase 1 | 2019-06-27 |
| Terminated | Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative S Schizophrenia | Phase 2 | 2019-04-22 |
| Completed | A Study Investigating Formulations of Vortioxetine Applied Under the Tongue in Healthy Subjects Healthy | Phase 1 | 2019-03-18 |
| Completed | Study With Vortioxetine on Emotional Functioning in Patients With Depression Major Depressive Disorder | Phase 4 | 2019-02-05 |
| Completed | A Positron Emission Tomography (PET) Study to Examine the Brain Binding Properties of a Novel Radioactive Comp Parkinson Disease | EARLY_Phase 1 | 2019-01-17 |
| Terminated | Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With Schizophrenia Schizophrenia | Phase 2 | 2018-12-27 |
| Terminated | Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to Alzheimer Disease | Phase 1 | 2018-12-12 |
| Completed | Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With Depressio Major Depressive Disorder | Phase 2 | 2018-12-03 |
| Completed | Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State Healthy | Phase 1 | 2018-09-05 |
| Completed | Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Condition Healthy | Phase 1 | 2018-08-28 |
| Completed | Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease Healthy, Parkinson Disease | Phase 1 | 2018-07-25 |
| Terminated | A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients Alzheimer's Disease | Phase 1 | 2018-06-26 |
| Completed | Single Dose of Lu AF28996 to Healthy Young Men Healthy | Phase 1 | 2018-05-29 |
| Completed | Bioequivalence Study to Compare Two Formulations of Deanxit® Healthy | Phase 1 | 2018-05-07 |
| Completed | Single Ascending Dose Study of Lu AF76432 in Healthy Young Men Healthy | Phase 1 | 2018-04-17 |
| Completed | Bioequivalence Study of Lu AF35700 Healthy | Phase 1 | 2018-01-03 |
| Completed | Real-life Effectiveness of Vortioxetine in Depression Major Depressive Disorder | — | 2017-11-17 |
| Terminated | Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease Alzheimer's Disease | Phase 1 | 2017-09-22 |
| Terminated | Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment Renal Failure | Phase 1 | 2017-07-25 |
| Terminated | Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia Treatment-resistant Schizophrenia | Phase 3 | 2017-07-20 |
| Completed | Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes Drug Reactions | Phase 1 | 2017-06-16 |
| Completed | Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment an Hepatic Impairment | Phase 1 | 2017-05-14 |
| Completed | Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Cytochrome P450 Interaction | Phase 1 | 2017-03-28 |
| Completed | Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to Depressive Disorder, Major | Phase 3 | 2017-03-01 |
| Completed | Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Depressive Disorder, Major | Phase 2 | 2016-09-27 |
| Withdrawn | Bioequivalence Study of Idalopirdine in Healthy Subjects Bioequivalence | Phase 1 | 2016-09-01 |
| Completed | Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizophrenia, Schizoaffective Disorder | Phase 1 | 2016-09-01 |
| Terminated | Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants Wit Depressive Disorder, Major | Phase 3 | 2016-08-17 |
| Completed | Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia Schizophrenia | Phase 3 | 2016-08-01 |
| Withdrawn | Comparison of the Effectiveness of Brexpiprazole With That of Risperidone Schizophrenia | Phase 3 | 2016-06-01 |
| Completed | Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years W Depressive Disorder, Major | Phase 3 | 2016-05-18 |
| Completed | Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Depressive Disorder, Major | Phase 3 | 2016-05-01 |
| Completed | Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia Schizophrenia | Phase 3 | 2016-04-01 |
| Completed | Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension Symptomatic Neurogenic Orthostatic Hypotension | Phase 4 | 2016-02-11 |
| Completed | An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 Parkinson Disease | Phase 1 | 2016-01-01 |
| Completed | Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations Bioequivalence Study in Healthy Subjects | Phase 1 | 2016-01-01 |
| Completed | Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzhe Alzheimer Dementia (AD) | Phase 4 | 2015-10-01 |
| Completed | Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men Healthy Volunteers | Phase 1 | 2015-05-01 |
| Completed | Investigating the Absorption, Metabolism and Excretion (AME) of Idalopirdine Healthy | Phase 1 | 2015-04-01 |
| Completed | Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women Pharmacokinetics | Phase 1 | 2015-03-01 |
| Completed | Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an In Major Depression Disorder | Phase 3 | 2015-03-01 |
| Terminated | Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dra Dravet Syndrome | Phase 3 | 2015-03-01 |
| Withdrawn | Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome Dravet Syndrome | Phase 3 | 2015-03-01 |
| Completed | Bioequivalence Study of Idalopirdine Tablets 60 mg Healthy | Phase 1 | 2015-03-01 |
| Terminated | Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Alzheimer Disease | Phase 1 | 2015-03-01 |
| Completed | Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function Alzheimer Disease | Phase 1 | 2015-01-01 |
| Completed | Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multipl Schizophrenia | Phase 1 | 2014-12-30 |
| Completed | Investigating the Effect of Vortioxetine in Adult ADHD Patients Attention Deficit Hyperactivity Disorder | Phase 2 | 2014-12-01 |
| Completed | Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Cur Major Depressive Disorder | Phase 3 | 2014-12-01 |
| Completed | Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder Major Depressive Disorder | Phase 3 | 2014-10-01 |
| Completed | Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressi Major Depressive Disorder | Phase 3 | 2014-10-01 |
| Completed | Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use Alcohol Dependence | Phase 4 | 2014-09-01 |
| Terminated | Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care Alcohol Dependence | Phase 4 | 2014-08-01 |
| Completed | Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167 Schizophrenia | Phase 1 | 2014-08-01 |
| Completed | Study to Evaluate the Effect of a Known and Marketed Product, Itraconazole (Mycosis Treatment) on Lu AF11167 E Healthy | Phase 1 | 2014-07-01 |
| Completed | Pharmacokinetics Properties of Single Oral Dosing of Lu AE58054 in Subjects With Hepatic Impairment (Mild and Heptic Impairment | Phase 1 | 2014-07-01 |
| Completed | Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitr Healthy Men and Women | Phase 1 | 2014-06-01 |
| Completed | Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patient Alzheimer's Disease | Phase 3 | 2014-04-07 |
| Completed | Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration Healthy Women | Phase 1 | 2014-04-01 |
| Completed | Effect of Multiple Doses of Itraconazole on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy Subjec Healthy Volunteers | Phase 1 | 2014-03-01 |
| Completed | Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesteras Alzheimer's Disease | Phase 3 | 2014-03-01 |
| Completed | D2 Dopamine Receptor Occupancy After Oral Dosing of Lu AF35700 in Healthy Men Using [11C]-PHNO as Tracer Compo Healthy Men | Phase 1 | 2014-02-01 |
| Completed | Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects Healthy Men | Phase 1 | 2014-02-01 |
| Completed | Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil Alzheimer's Disease | Phase 3 | 2014-02-01 |
| Completed | Absolute Bioavailability of Lu AE58054 in Healthy Subjects Healthy | Phase 1 | 2013-12-01 |
| Terminated | Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-tra Post-traumatic Stress Disorder, PTSD | Phase 3 | 2013-12-01 |
| Completed | Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral S Alcohol Dependence | Phase 1 | 2013-11-01 |
| Completed | Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil Alzheimer's Disease | Phase 3 | 2013-10-01 |
| Completed | Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia Schizophrenia | Phase 1 | 2013-10-01 |
| Terminated | Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depres Major Depressive Disorder | Phase 3 | 2013-10-01 |
| Completed | Aripiprazole Once-monthly in Patients With Schizophrenia Schizophrenia | Phase 3 | 2013-10-01 |
| Completed | Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and Major Depressive Disorder, Irritability | Phase 3 | 2013-10-01 |
| Completed | Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorde Sleep Disturbances | Phase 3 | 2013-09-01 |
| Completed | Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese Healthy | Phase 1 | 2013-07-01 |
| Completed | Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects Renal Impairment | Phase 1 | 2013-07-01 |
| Completed | Brexpiprazole in Patients With Schizophrenia Schizophrenia | Phase 3 | 2013-07-01 |
| Completed | Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response t Major Depressive Disorder | Phase 3 | 2013-06-01 |
| Terminated | Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorde Major Depressive Disorder | Phase 3 | 2013-04-01 |
| Completed | Brexpiprazole in Patients With Acute Schizophrenia Schizophrenia | Phase 3 | 2013-03-01 |
| Completed | Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia Schizophrenia | Phase 3 | 2013-02-01 |
| Completed | Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia Schizophrenia | Phase 1 | 2013-01-01 |
| Completed | Pharmacokinetic Properties of Lu AA21004 (Vortioxetine) in Healthy Young Chinese Men and Women Healthy | Phase 1 | 2012-10-01 |
| Completed | Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (B Depression | Phase 1 | 2012-07-01 |
| Completed | Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women Parkinson's Disease | Phase 1 | 2012-05-01 |
| Completed | Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries Major Depressive Disorder | Phase 3 | 2012-05-01 |
| Completed | Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China Parkinson's Disease | Phase 3 | 2012-04-01 |
| Completed | Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressiv Depressive Disorder, Anxiety Disorder | Phase 2 | 2012-04-01 |
| Completed | A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression Wi Major Depressive Disorder | Phase 3 | 2012-01-01 |
| Completed | Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder Major Depressive Disorder | Phase 3 | 2011-12-01 |
| Completed | Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China Parkinson's Disease | Phase 3 | 2011-12-01 |
| Completed | Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophre Schizophrenia | Phase 2 | 2011-07-01 |
| Completed | Safety and Efficacy of Zicronapine in Patients With Schizophrenia Schizophrenia | Phase 3 | 2011-04-01 |
| Completed | Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Major Depressive Disorder | Phase 3 | 2011-04-01 |
| Completed | A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder Major Depressive Disorder | — | 2011-02-01 |
| Completed | Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Kor Parkinson's Disease | Phase 3 | 2011-01-01 |
| Completed | Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxeti Major Depressive Disorder | Phase 3 | 2010-05-01 |
| Completed | Bioequivalence Study Comparing Two Formulations of Escitalopram Healthy | Phase 1 | 2010-01-01 |
| Completed | Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease Alzheimer's Disease | Phase 2 | 2009-12-01 |
| Completed | Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Friedreich's Ataxia | Phase 2 | 2009-10-01 |
| Completed | Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic S Acute Ischemic Stroke | Phase 1 | 2009-05-01 |
| Terminated | Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4) Stroke | Phase 3 | 2009-04-01 |
| Completed | Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence Alcohol Dependence | Phase 3 | 2009-03-01 |
| Completed | Efficacy of Nalmefene in Patients With Alcohol Dependence Alcohol Dependence | Phase 3 | 2009-03-01 |
| Completed | Escitalopram in Patients With Generalized Anxiety Disorder Generalized Anxiety Disorder | Phase 4 | 2009-03-01 |
| Completed | Escitalopram in Patients With Social Anxiety Disorder Social Anxiety Disorder | Phase 4 | 2009-03-01 |
| Completed | Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu A Major Depressive Disorder | Phase 3 | 2009-01-01 |
| Completed | Efficacy of Nalmefene in Patients With Alcohol Dependence Alcohol Dependence | Phase 3 | 2008-12-01 |
| Terminated | Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression Bipolar Disorder | Phase 2 | 2008-12-01 |
| Completed | Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke Stroke | Phase 3 | 2008-12-01 |
| Completed | Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder Major Depressive Disorder | Phase 2 | 2008-11-01 |
| Completed | Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia Schizophrenia, Cognition | Phase 2 | 2008-11-01 |
| Completed | Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder Generalized Anxiety Disorder | Phase 3 | 2008-10-01 |
| Terminated | Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder Major Depressive Disorder | Phase 2 | 2008-09-01 |
| Completed | Efficacy of Lu 31-130 in Patients With Schizophrenia Schizophrenia | Phase 2 | 2008-09-01 |
| Terminated | Efficacy of Bifeprunox in Patients With Schizophrenia Schizophrenia | Phase 3 | 2008-06-01 |
| Completed | Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of M Major Depressive Disorder | Phase 3 | 2008-05-01 |
| Completed | Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophren Schizophrenia, Cognition | Phase 3 | 2008-03-01 |
| Terminated | Efficacy of Bifeprunox in Patients With Schizophrenia Schizophrenia | Phase 3 | 2008-03-01 |
| Completed | Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxet Major Depressive Disorder | Phase 3 | 2008-02-01 |
| Terminated | Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression Depression in Patients With Bipolar Disorder | Phase 2 | 2008-01-01 |
| Completed | Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes Major Depressive Disorder | Phase 3 | 2007-12-01 |
| Completed | Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia Schizophrenia | Phase 4 | 2007-11-01 |
| Completed | Dose-finding Study With Lu AA24530 in Major Depressive Disorder Major Depressive Disorder | Phase 2 | 2007-10-01 |
| Completed | Safety Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke Acute Ischemic Stroke | Phase 1 | 2007-10-01 |
| Completed | Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Major Depressive Disorder | Phase 2 | 2007-06-01 |
| Completed | Sertindole in Asian Patients With Schizophrenia Schizophrenia | Phase 3 | 2007-03-01 |
| Completed | Efficacy of Lu 31-130 in Patients With Schizophrenia Schizophrenia | Phase 2 | 2007-03-01 |
| Completed | Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia Schizophrenia | Phase 3 | 2007-03-01 |
| Completed | Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies Parkinson's Disease Dementia, Dementia With Lewy Bodies | Phase 4 | 2007-01-01 |
| Completed | Exploratory Cognition Study of Sertindole in Patients With Schizophrenia Schizophrenia | Phase 3 | 2006-10-01 |
| Terminated | Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED) Primary Insomnia | Phase 3 | 2006-09-01 |
| Completed | Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxeti Major Depressive Disorder | Phase 2 | 2006-08-01 |
| Terminated | Bifeprunox Extension to Extension Study in Patients With Schizophrenia Schizophrenia | Phase 3 | 2006-01-01 |
| Terminated | Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED) Primary Insomnia | Phase 2 | 2005-11-01 |
| Completed | MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED) Primary Insomnia | Phase 2 | 2005-11-01 |
| Completed | A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease Alzheimer's Disease | Phase 4 | 2005-09-01 |
| Completed | Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder Major Depressive Disorder | Phase 4 | 2005-09-01 |
| Completed | An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED) Insomnia | Phase 3 | 2005-02-01 |
| Completed | Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED) Insomnia | Phase 3 | 2005-02-01 |
| Withdrawn | An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007) Insomnia | Phase 3 | 2005-01-01 |
| Terminated | Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED) Primary Insomnia | Phase 3 | 2004-11-01 |
| Completed | Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED) Primary Insomnia | Phase 3 | 2004-11-01 |
| Completed | Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED) Insomnia | Phase 3 | 2004-10-01 |
| Completed | Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED) Insomnia | Phase 3 | 2004-10-01 |
| Completed | A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia Primary Insomnia | Phase 3 | 2004-07-01 |
| Completed | A Study of Gaboxadol in Primary Insomnia Primary Insomnia | Phase 3 | 2004-06-01 |
| Terminated | Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease Alzheimer's Disease | Phase 3 | 2004-06-01 |
| Completed | A Study of Gaboxadol in Primary Insomnia Primary Insomnia | Phase 3 | 2004-04-01 |
| Terminated | Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease Alzheimer's Disease | Phase 3 | 2003-12-01 |
| Completed | A Study of Gaboxadol in Primary Insomnia Primary Insomnia | Phase 3 | 2003-06-01 |
| Completed | A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia Primary Insomnia | Phase 3 | 2003-01-01 |
| Completed | Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use Schizophrenia | Phase 3 | 2002-07-01 |